Skip to main content
ABL Bio Inc. logo

ABL Bio Inc. — Investor Relations & Filings

Ticker · 298380 ISIN · KR7298380007 LEI · 9884007BRC71Y64NK235 KO Professional, scientific and technical activities
Open in API
Filings indexed 368 across all filing types
Latest filing 2022-02-11 Earnings Release
Country KR South Korea
Listing KO 298380

About ABL Bio Inc.

https://www.ablbio.com

ABL Bio Inc. is a clinical-stage biotechnology company specializing in the development of bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases. The company leverages several proprietary platforms. For central nervous system disorders, its 'Grabody-B' technology is a blood-brain barrier (BBB) penetrating shuttle designed to enhance drug delivery to the brain. In immuno-oncology, ABL Bio develops 4-1BB based bispecific antibodies aimed at minimizing toxicity and overcoming resistance to existing immunotherapies. The company is also advancing a pipeline of antibody-drug conjugates (ADCs) with an improved therapeutic index for conditions such as rare blood cancers. ABL Bio actively progresses its therapeutic candidates through clinical development.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (ABL Bio) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for preliminary earnings results. Since it provides specific financial figures and reasons for the variance rather than just announcing the publication of a report, it is classified as an Earnings Release (ER). FY 2021
2022-02-11 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location (YouTube), and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it is a short regulatory notice, it fits the definition of a Report Publication Announcement or general regulatory filing regarding corporate events.
2022-02-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of the company's major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-01-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special related parties, including specific transaction dates, methods (market sales), and updated shareholding percentages. This falls under the category of 'Major Shareholding Notification'.
2022-01-21 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It specifies the date, location, purpose, and participants of the event. Since it is an announcement of an event and the availability of materials rather than the presentation itself, and it fits the regulatory announcement format for corporate events, it is classified as a Regulatory Filing (RNS).
2022-01-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, purpose, and target audience for the presentation. It is not the presentation itself, but rather a notification of the event and the availability of materials. According to the 'Menu vs Meal' rule, announcements of events or report publications are classified as Report Publication Announcements (RPA) or Regulatory Filings (RNS). Given the specific nature of the announcement regarding an IR event, it fits best as a Regulatory Filing (RNS) or an announcement of an event.
2022-01-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.